• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对霉素对蛋白质合成终止过程的特异性抑制作用。

Specific inhibition of the termination process of protein synthesis by negamycin.

作者信息

Uehara Y, Hori M, Umezawa H

出版信息

Biochim Biophys Acta. 1976 Aug 18;442(2):251-62. doi: 10.1016/0005-2787(76)90495-0.

DOI:10.1016/0005-2787(76)90495-0
PMID:782542
Abstract

The effect of negamycin and its derivatives on protein synthesis in an Escherichia coli cell-free system was determined. (1) Unlike tetracycline and streptomycin, negamycin did not inhibit codon-specific binding of aminoacyl-tRNA to ribosomes. (2) The miscoding activity of the genamycin family compounds was not parallel with the activity inhibiting the termination reaction. (3) Although negamycin strongly inhibited the overall termination reaction, it inhibited only slightly the two substeps involved; the formation of releasing factor 1 - U-A-[3H]G - ribosome complex and the peptidyl-transferase action (release of formylmethionine from the initiation complex by puromycin). (4) The termination reaction performed with ribosomes from either streptomycin- or kanamycin-resistant E. coli cells was sensitive to negamycin. These results indicate that the inhbitory effect of negamycin on the termination reaction is specific to negamycin and distinct from that of tetracycline and streptomycin.

摘要

测定了Negamycin及其衍生物对大肠杆菌无细胞体系中蛋白质合成的影响。(1)与四环素和链霉素不同,Negamycin不抑制氨酰-tRNA与核糖体的密码子特异性结合。(2)庆大霉素家族化合物的错义编码活性与抑制终止反应的活性不平行。(3)虽然Negamycin强烈抑制整体终止反应,但仅轻微抑制所涉及的两个子步骤;释放因子1-U-A-[3H]G-核糖体复合物的形成和肽基转移酶作用(嘌呤霉素从起始复合物中释放甲酰甲硫氨酸)。(4)用来自抗链霉素或抗卡那霉素的大肠杆菌细胞的核糖体进行的终止反应对Negamycin敏感。这些结果表明,Negamycin对终止反应的抑制作用是Negamycin特有的,且与四环素和链霉素不同。

相似文献

1
Specific inhibition of the termination process of protein synthesis by negamycin.对霉素对蛋白质合成终止过程的特异性抑制作用。
Biochim Biophys Acta. 1976 Aug 18;442(2):251-62. doi: 10.1016/0005-2787(76)90495-0.
2
Inhibitors of protein synthesis.蛋白质合成抑制剂。
FEBS Lett. 1974 Mar 23;40(0):suppl:S63-84. doi: 10.1016/0014-5793(74)80689-7.
3
The use of inhibitors in studies on protein synthesis.抑制剂在蛋白质合成研究中的应用。
Methods Enzymol. 1974;30:261-82. doi: 10.1016/0076-6879(74)30030-4.
4
Peptidyl transferase inhibitors alter the covalent reaction of BrAcPhe-tRNA with the E. coli ribosome.肽基转移酶抑制剂会改变溴乙酰苯丙氨酰 - tRNA与大肠杆菌核糖体的共价反应。
FEBS Lett. 1974 Sep 1;45(1):218-22. doi: 10.1016/0014-5793(74)80848-3.
5
Characteristics of N-Ac-Phe-tRNA binding and its correlation with internal aminoacyl-tRNA recognition.N-乙酰苯丙氨酰-tRNA的结合特性及其与内部氨酰-tRNA识别的相关性
Biochem Biophys Res Commun. 1972 Apr 28;47(2):477-84. doi: 10.1016/0006-291x(72)90739-5.
6
The effect of antibiotics on the coded binding of peptidyl-tRNA to the ribosome and on the transfer of the peptidyl residue to puromycin.抗生素对肽基 - tRNA与核糖体的编码结合以及肽基残基向嘌呤霉素转移的影响。
Eur J Biochem. 1969 May 1;9(1):27-35. doi: 10.1111/j.1432-1033.1969.tb00571.x.
7
The mode of action of pleuromutilin derivatives. Effect on cell-free polypeptide synthesis.截短侧耳素衍生物的作用模式。对无细胞多肽合成的影响。
Eur J Biochem. 1974 Sep 16;47(3):527-33. doi: 10.1111/j.1432-1033.1974.tb03721.x.
8
Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro.Negamycin在体外抑制噬菌体f2 RNA指导的蛋白质合成终止。
Biochim Biophys Acta. 1974 Nov 20;374(1):82-95. doi: 10.1016/0005-2787(74)90201-9.
9
Mode of action of antibiotics on various steps of protein synthesis.抗生素对蛋白质合成各个步骤的作用模式。
Adv Cytopharmacol. 1971 May;1:99-111.
10
Release factor binding to ribosome requires an intact 16 S rRNA 3' terminus.释放因子与核糖体的结合需要完整的16 S rRNA 3'末端。
J Biol Chem. 1977 Jul 10;252(13):4435-7.

引用本文的文献

1
The Antibiotic Negamycin Crosses the Bacterial Cytoplasmic Membrane by Multiple Routes.抗生素奈加霉素通过多种途径穿过细菌细胞质膜。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.00986-20.
2
CTELS: A Cell-Free System for the Analysis of Translation Termination Rate.CTELS:一种用于分析翻译终止速率的无细胞系统。
Biomolecules. 2020 Jun 16;10(6):911. doi: 10.3390/biom10060911.
3
Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.核糖体靶向抗生素:作用模式、耐药机制及对药物设计的启示。
Annu Rev Biochem. 2018 Jun 20;87:451-478. doi: 10.1146/annurev-biochem-062917-011942. Epub 2018 Mar 23.
4
An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome.一种通过将释放因子捕获在核糖体上来抑制翻译的抗菌肽。
Nat Struct Mol Biol. 2017 Sep;24(9):752-757. doi: 10.1038/nsmb.3439. Epub 2017 Jul 24.
5
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.结构见解催生了一种对革兰氏阴性病原体具有增强抗菌活性的Negamycin类似物。
ACS Med Chem Lett. 2015 Jul 12;6(8):930-5. doi: 10.1021/acsmedchemlett.5b00205. eCollection 2015 Aug 13.
6
Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.Negamycin通过与大肠杆菌核糖体的小亚基头部结构域结合,诱导翻译停滞和错义编码。
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16274-9. doi: 10.1073/pnas.1414401111. Epub 2014 Nov 3.
7
Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.Negamycin通过与rRNA和tRNA同时相互作用来干扰解码和转位。
Mol Cell. 2014 Nov 20;56(4):541-50. doi: 10.1016/j.molcel.2014.09.021. Epub 2014 Oct 9.
8
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases.抑制无义突变作为治疗遗传疾病的一种方法。
Wiley Interdiscip Rev RNA. 2011 Nov-Dec;2(6):837-52. doi: 10.1002/wrna.95. Epub 2011 Jul 6.
9
Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit.Negamycin与50S核糖体亚基新生链出口通道的壁结合。
Antimicrob Agents Chemother. 2007 Dec;51(12):4462-5. doi: 10.1128/AAC.00455-07. Epub 2007 Jul 30.
10
Two regions of the Escherichia coli 16S ribosomal RNA are important for decoding stop signals in polypeptide chain termination.大肠杆菌16S核糖体RNA的两个区域对于多肽链终止过程中终止信号的解码至关重要。
Nucleic Acids Res. 1993 May 11;21(9):2109-15. doi: 10.1093/nar/21.9.2109.